Protocol
INTRODUCTION
Trypan blue stains vasculature, dead plant cells, and fungal and oomycete hyphae. It is useful for assessing the extent of colonization of tissue, and for detecting microlesions present in certain lesionmimic mutants. Trypan blue staining requires chloral hydrate for destaining, which is inconvenient, because it is a controlled substance. The chloral hydrate can be replaced with 1:2 lactophenol:ethanol, but the background staining will be higher than it is when chloral hydrate is used.
RELATED INFORMATION
For information about obtaining a mutant in Arabidopsis, see Setting Up Arabidopsis Crosses (Weigel and Glazebrook 2006) , Genetic Analysis of Arabidopsis Mutants (Weigel and Glazebrook 2008) , and the Discussion. See Keogh et al. (1980) for a description of trypan blue staining in fungal tissue. For a description of lesion-mimic mutants, see Dangl et al. (1996) . i. Add trypan blue to lactophenol to a concentration of 2.5 mg/mL.
Reagents
ii. Add 2 volumes of ethanol to the trypan blue-lactophenol solution.
2. Place the tissue to be stained in the wells of a 12-well microtiter plate. Cover the tissue with the staining solution from Step 1.ii, and heat in a boiling water bath for 1 min.
3. Allow the plate to sit at room temperature for 1-24 h. (Begin with 1 h; if samples are not stained well enough, increase the time of incubation.)
4.
Remove the staining solution, and cover the tissue in chloral hydrate solution. Incubate for 2-6 h at room temperature.
The staining solution may be saved and reused. This practice helps to minimize the amount of phenol waste generated.
5.
Replace the chloral hydrate solution, and incubate overnight at room temperature.
6. Remove the chloral hydrate solution, and cover the tissue in 70% glycerol.
7.
Examine the tissue using a compound microscope.
For examples of trypan blue staining of dead plant cells, Peronospora parasitica in leaves, and Fusarium oxysporum in leaves, see Rate et al. (1999) , Petersen et al. (2000) , and Epple et al. (1997) , respectively.
DISCUSSION
Two methods of obtaining a mutant are by directed screening for plants with a certain phenotype and by knocking out a gene of interest. The phenotypes of knock-out mutants are difficult to predict, and it is also quite common for mutants, first isolated because of a specific phenotype, to have other, pleiotropic defects, i.e., multiple defects in addition to that of primary interest. Thus, it is often necessary to characterize a variety of phenotypic parameters. This is particularly important as the field of molecular genetics expands. If a number of groups, each looking for a different phenotype, independently identify different mutations in the same gene, an awareness of additional defects will often show that the new mutation is allelic to existing mutants. Before embarking on an extensive phenotypic characterization, it is important to confirm that the various phenotypes of an individual are genetically linked (see Setting Up Arabidopsis Crosses [Weigel and Glazebrook 2006] and Genetic Analysis of Arabidopsis Mutants [Weigel and Glazebrook 2008] ). Strictly speaking, all of the phenotypes should be mapped, but it is normally sufficient to backcross a newly isolated mutant about five times to remove defects due to unlinked mutations. Phenotype mapping becomes more important, however, when dealing with a mutant that has been isolated by site-selected mutagenesis (T-DNA or transposon knock-out). In this case, it must be shown that any phenotype cosegregates with the induced mutation. Definitive proof that a phenotype is indeed due to the disrupted gene can only come from complementing the mutant with a wild-type copy of the disrupted gene or by constructing trans-heterozygotes carrying two independently isolated mutations.
